ONCOGENICITY OF IMMUNOSUPPRESSIVE DRUGS
- 5 February 1972
- journal article
- other
- Published by Elsevier in The Lancet
- Vol. 299 (7745) , 326-327
- https://doi.org/10.1016/s0140-6736(72)90341-8
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- SKIN CANCER AND IMMUNOSUPPRESSIONThe Lancet, 1971
- Studies on the absorption and metabolism of folic acidJournal of Clinical Investigation, 1971
- DE-NOVO BRAIN TUMOURS IN RENAL-TRANSPLANT RECIPIENTSThe Lancet, 1971
- A study of folate absorption and metabolism in man utilizing carbon-14—labeled polyglutamates synthesized by the solid phase methodJournal of Clinical Investigation, 1969
- Absorption of Polyglutamic Folate: Participation of Deconjugating Enzymes of the Intestinal MucosaNew England Journal of Medicine, 1969
- Absorption and Utilization of Polyglutamyl Forms of Folate in ManBMJ, 1968
- MECHANISM OF FOLATE DEFICIENCY IN PATIENTS RECEIVING PHENYTOINThe Lancet, 1968
- IMPAIRMENT OF INTESTINAL DECONJUGATION OF DIETARY FOLATE: A Possible Explanation of Megaloblastic Anæmia Associated with Phenytoin TherapyThe Lancet, 1968
- CYCLOPHOSPHAMIDE TREATMENT OF KIDNEY DISEASE IN (NZB X NZW) F1 MICEThe Lancet, 1966
- STUDIES ON THE IDENTIFICATION OF A FOLATE COMPOUND OF HUMAN SERUM*Journal of Clinical Investigation, 1962